{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:18:53Z","timestamp":1786990733672,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijid.2025.108174","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:00:21Z","timestamp":1761843621000},"page":"108174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Disease pattern and risk factors of antimicrobial resistance in patients with pneumococcal infection in the Hong Kong population"],"prefix":"10.1016","volume":"161","author":[{"given":"Jack Chi-him","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith Wai-ki","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk-ching","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Chi-chung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza Yuen-ting","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike Yat-Wah","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fan Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi-Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Kin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaya","family":"Sukarom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Shijian","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine Sze-Ling","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108174_bib0001","doi-asserted-by":"crossref","first-page":"ofaa146","DOI":"10.1093\/ofid\/ofaa146","article-title":"Adherence to treatment guideline improves patient outcomes in a prospective cohort of adults hospitalized for community-acquired pneumonia","volume":"7","author":"Lui","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0002","article-title":"Updated recommendations on the use of pneumococcal vaccines for high-risk individuals. Hong Kong: The Government of the Hong Kong Special Administrative Region","year":"2016","journal-title":"PRC"},{"key":"10.1016\/j.ijid.2025.108174_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220951","article-title":"Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: a need to expand vaccination policy?","volume":"14","author":"Martinez-Vega","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108174_bib0004","doi-asserted-by":"crossref","first-page":"ofab063","DOI":"10.1093\/ofid\/ofab063","article-title":"A multicenter evaluation of the US prevalence and regional variation in macrolide-resistant S. pneumoniae in ambulatory and hospitalized adult patients in the United States","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2025.108174_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0924-8579(02)00127-9","article-title":"Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains","volume":"20","author":"Quach","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijid.2025.108174_bib0007","doi-asserted-by":"crossref","first-page":"512.e1","DOI":"10.1016\/j.cmi.2019.09.008","article-title":"Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017","volume":"26","author":"Varghese","year":"2020","journal-title":"Clinical microbio. infection\u202f: official publicat. European Soc. Clin. Microbio. Infect. Dise."},{"key":"10.1016\/j.ijid.2025.108174_bib0008","first-page":"4","article-title":"Invasive pneumococcal disease in Hong Kong children","volume":"9","author":"Chan","year":"2013","journal-title":"J Paediatr Respirol Crit Care"},{"key":"10.1016\/j.ijid.2025.108174_bib0009","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3201\/eid0705.010526","article-title":"Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone","volume":"7","author":"Ho","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0010","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":"High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2025.108174_bib0011","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/vaccines9070756","article-title":"Persistence of pneumococcal Serotype 3 in adult pneumococcal disease in Hong Kong","volume":"9","author":"Subramanian","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2025.108174_bib0012","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.45.10.2765-2770.2001","article-title":"Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong","volume":"45","author":"Chiu","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2025.108174_bib0013","first-page":"262","article-title":"New Impact Guideline to help doctors on rational prescription of antimicrobials","volume":"31","author":"Ma","year":"2025","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ijid.2025.108174_bib0016","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40264-020-00920-9","article-title":"Patterns of inpatient antibiotic use among public hospitals in Hong Kong from 2000 to 2015","volume":"43","author":"Chui","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijid.2025.108174_bib0017","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/21645515.2018.1526555","article-title":"Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the Pneumococcal Conjugate Vaccine in Hong Kong","volume":"15","author":"Ho","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2025.108174_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7883\/yoken.JJID.2016.311","article-title":"Serotype replacement in adult pneumococcal pneumonia after the introduction of seven-valent pneumococcal conjugate vaccines for children in Japan: a systematic literature review and pooled data analysis","volume":"70","author":"Katoh","year":"2017","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0019","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3201\/eid2910.230519","article-title":"Serotype distribution and disease severity in adults hospitalized with Streptococcus pneumoniae infection, bristol and Bath, UK, 2006\u20132022","volume":"29","author":"Hyams","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jmii.2022.08.018","article-title":"Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2025.108174_bib0021","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in 10 countries","volume":"28","author":"Hanquet","year":"2022","journal-title":"Europe. Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0022","article-title":"Population structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in Victoria","volume":"9","author":"Higgs","year":"2023","journal-title":"Australia. Microb Genom"},{"key":"10.1016\/j.ijid.2025.108174_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106178","article-title":"Increased incidence of invasive pneumococcal disease in Hong Kong in 2023","volume":"89","author":"Pang","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108174_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.socscimed.2004.12.029","article-title":"Health Care Financing Study Group. The ecology of health care in Hong Kong","volume":"61","author":"Leung","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijid.2025.108174_bib0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/EDE.0000000000000325","article-title":"Brief report: databases in the Asia-pacific region: the potential for a distributed network approach","volume":"26","author":"Lai","year":"2015","journal-title":"Epidemiology"},{"key":"10.1016\/j.ijid.2025.108174_bib0026","unstructured":"Hospital Authority. Clusters, hospitals & institutions: Hospital Authority, https:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10036&Lang=ENG&Ver=HTML; 2023 [accessed 01 Sept 2023]."},{"key":"10.1016\/j.ijid.2025.108174_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.289.1.87","article-title":"The prevalence of autism","volume":"289","author":"Fombonne","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2025.108174_bib0028","first-page":"676","article-title":"Medication safety research by observational study design","volume":"38","author":"Lao","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ijid.2025.108174_bib0029","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1016\/j.vaccine.2011.02.025","article-title":"Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent Pneumococcal Conjugate Vaccine, Hong Kong, 1995\u20132009","volume":"29","author":"Ho","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1186\/s12889-022-14051-6","article-title":"Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998\u20132018","volume":"22","author":"Hu","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2025.108174_bib0031","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41479-023-00109-5","article-title":"Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis","volume":"15","author":"Hu","year":"2023","journal-title":"Pneumonia (Nathan)"},{"key":"10.1016\/j.ijid.2025.108174_bib0032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12879-022-07275-9","article-title":"Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent Pneumococcal Conjugate Vaccines during 1998\u20132018","volume":"22","author":"Hu","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0033","series-title":"Table 110-01001A : Mid-year population (excluding foreign domestic helpers) by Sex and Age group. Demographic statistics section CaSD","year":"2023"},{"key":"10.1016\/j.ijid.2025.108174_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055575","article-title":"Invasive pneumococcal disease, pneumococcal pneumonia and all-cause pneumonia in Hong Kong during the COVID-19 pandemic compared with the preceding 5 years: a retrospective observational study","volume":"11","author":"Chan","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2025.108174_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12879-016-1820-8","article-title":"Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake","volume":"16","author":"Dyda","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108174_bib0036","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.vaccine.2019.11.026","article-title":"Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia","volume":"38","author":"Forstner","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0037","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","article-title":"Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: a study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)","volume":"37","author":"LeBlanc","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2025.108174_bib0039","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.vaccine.2022.03.004","article-title":"Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: serotype-dependent difference in ceftriaxone susceptibility","volume":"40","author":"Yoon","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0040","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2020.04.048","article-title":"Increasing non-susceptibility to antibiotics within carried pneumococcal serotypes \u2013 Alaska, 2008\u20132015","volume":"38","author":"Plumb","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0042","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype","volume":"49","author":"S\u00e1-Le\u00e3o","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2025.108174_bib0043","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2019.10.056","article-title":"Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany","volume":"38","author":"Goettler","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108174_bib0044","series-title":"Communicable Disease Branch of the Centre for Health Protection","year":"2024"},{"key":"10.1016\/j.ijid.2025.108174_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278072","article-title":"Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: a population-based study","volume":"17","author":"Aboulatta","year":"2022","journal-title":"PLoS One"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:01:19Z","timestamp":1780664479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"alternative-id":["S1201971225003960"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108174","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease pattern and risk factors of antimicrobial resistance in patients with pneumococcal infection in the Hong Kong population","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s) and Merck & Co., Inc., Rahway, NJ, USA and its affiliates. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108174"}}